A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China-Reference-Cited by-同舟云学术

A cost-effectiveness analysis of first-line toripalimab plus chemotherapy in advanced nonsquamous non-small cell lung cancer in China

Published:2023-03-04 Issue:3 Volume:16 Page:267-273
ISSN:1751-2433
Container-title:Expert Review of Clinical Pharmacology
language:en
Short-container-title:Expert Review of Clinical Pharmacology

Author:

Zheng Zhiwei¹,Zhu Gaofeng²,Cao Xueqiong³,Cai Hongfu³,Zhu Huide¹

Affiliation:

1. Department of Pharmacy, Cancer Hospital of Shantou University Medical College, Shantou, China

2. Department of Emergency Medicine, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China

3. Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, China

Funder

Shantou Science and Technology Project

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17512433.2023.2188194

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

3. Lung cancer in China: current and prospect

4. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

5. Lung cancer: current therapies and new targeted treatments

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab combined with chemotherapy versus placebo combined with chemotherapy for HER2-negative advanced gastric cancer in China: a cost-effectiveness analysis;Expert Review of Pharmacoeconomics & Outcomes Research;2024-07-12

2. Cost-effectiveness analysis of serplulimab combination therapy versus chemotherapy alone for patients with extensive-stage small cell lung cancer;Frontiers in Oncology;2024-01-11

3. Relationship between Changes of Serum Vascular Endothelial Growth Factor and Folate Receptor-α Levels and Clinical Efficacy of Toripalimab in Patients with Bladder Cancer;Archivos Españoles de Urología;2024